Johnson & Johnson Consumer Sales Continue to Drop, 2011 to 2013
Johnson & Johnson consumer goods sales continue to slide in 2013 due to boycotts, recalls and more carcinogens in baby care products.
Keywords: jnj, johnson and johnson, johnson & johnson, J&J, boycott, recall, baby, products
Date Created/Edited: 2013, May 12
The complete list of content on the site
Risperdal US DEATH Warning for Elderly Dementia NOT Applied in AU Q to Alex Gorsky, Chairman/CEO of Johnson and Johnson, would you give your USA banned drug Risperdal to your father, if he had dementia?
United States Senate HELPless Committee The US Senate Committee on Health, Education, Labor and Pensions is supposed to be looking out for best interest of voters, but seems to be taking cash from BOTH sides and protecting corruption at Johnson & Johnson and Obama administration.
List of Interesting Visitors to the Johnson and Toxin web site (colleges, universities, law firms, journalists, financial institutions,...)
2015 Consumer Letter to Johnson & Johnson Shareholders
Honoring Request to Say Something Nice About Johnson & Johnson
2015 Johnson & Johnson US Lawsuit Update: Jump from 48,500 to 56.500.
Numerous groups have called for boycotts of Johnson & Johnson products for a variety of reasons. In addition, as more mothers in the United States are educated regarding known carcinogens in the U.S. formulation of baby soap, shampoo, powder, lotions, creams and other baby products as well as the same carcinogens in adult care products, it is obvious that the sales of J&J toxic consumer products are suffering as consumers choose less toxic products.
2011 : 2011 consumer sales : U.S. decrease 6.7% / Int increase 7.3 / WW increase 2.0%
http://www.investor.jnj.com/2011annualreport/pdf/JNJ-2011_ManagementsDiscussion_AnalysisSales.pdf page 2 of 11
2012 : 1st quarter consumer sales : U.S. decrease 2.2% / Int decrease 2.5% / WW decrease 2.4%
Worldwide Consumer sales of $3.6 billion for the first quarter represented a decrease of 2.4% versus the prior year consisting of an operational decline of 0.6% and a negative impact from currency of 1.8%. Domestic sales decreased 2.2%. International sales decreased 2.5%, which reflected an operational increase of 0.4% and a negative currency impact of 2.9%.
2012 : 2nd quarter consumer sales : U.S. decrease 1.9% / Int decrease 6.0% / WW decrease 4.6%
Worldwide Consumer sales of $3.6 billion for the second quarter represented a decrease of 4.6% versus the prior year consisting of an operational increase of 0.6% and a negative impact from currency of 5.2%. Domestic sales decreased 1.9%. International sales decreased 6.0%, which reflected an operational increase of 2.0% and a negative currency impact of 8.0%.
2012 : 3rd quarter consumer sales : U.S. decrease 4.3% / Int decrease 6.1% / WW decrease 4.3%
Worldwide Consumer sales of $3.6 billion for the third quarter represented a decrease of 4.3% versus the prior year consisting of an operational increase of 1.0% and a negative impact from currency of 5.3%. Domestic sales decreased 0.4%. International sales decreased 6.1%, which reflected an operational increase of 1.8% and a negative currency impact of 7.9%.
2012 : full year consumer sales : U.S. decrease 2% / Int decrease 3.4% / WW decrease 2.9%
Worldwide Consumer sales of $14.4 billion for the full-year 2012 represented a decrease of 2.9% versus the prior year, consisting of an operational increase of 0.5% and a negative impact from currency of 3.4%. Domestic sales decreased 2.0%; international sales decreased 3.4%, which reflected an operational increase of 1.9% and a negative currency impact of 5.3%.
With yet another recall of Children's Tylenol and yet another undisclosed carcinogen found in yet another baby care product, I don't see Johnson & Johnson consumer sales rebounding any time soon. I don't know, maybe people don't want to risk using products on their children that might harm their precious babies. As people like me continue sharing the risks as fast as we can with other moms so they don't use toxic products, I think sales will likely continue to drop.
Something to consider: As fewer people use toxic products from Johnson & Johnson, the rate of long-term illnesses, such as asthma, allergies, chronic sinus infections, COPD, cancer, low fertility, and such, caused by these products (and the drugs prescribed to deal with side effects of the drugs prescribed) will begin to decline - cutting into Johnson & Johnson medical devices and pharmaceuticals sales ;o)
1. Elizabeth Lopatto (2013, May 3). J&J Recalls Some Children’s Tylenol in South Korea Bloomberg. Retrieved from http://www.bloomberg.com/news/2013-05-03/j-j-recalls-some-children-s-tylenol-in-south-korea.html
2. Ganesh N (2013, April 25). FDA suspends J&J Licence New indian Express. Retrieved from http://www.newindianexpress.com/nation/FDA-suspends-JJ-Licence/2013/04/25/article1560077.ece